These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 12860866)

  • 21. Effect of nisoldipine on exercise performance in heart failure following myocardial infarction.
    Lewis BS; Makhoul N; Merdler A; Flugelman MY; Front A; Hardoff R; Halon DA
    Cardiology; 1991; 79(1):39-45. PubMed ID: 1777913
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): randomised controlled trial.
    Poole-Wilson PA; Lubsen J; Kirwan BA; van Dalen FJ; Wagener G; Danchin N; Just H; Fox KA; Pocock SJ; Clayton TC; Motro M; Parker JD; Bourassa MG; Dart AM; Hildebrandt P; Hjalmarson A; Kragten JA; Molhoek GP; Otterstad JE; Seabra-Gomes R; Soler-Soler J; Weber S;
    Lancet; 2004 Sep 4-10; 364(9437):849-57. PubMed ID: 15351192
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improvement of silent myocardial ischaemia and reduction of plasma fibrinogen during nisoldipine therapy in occult coronary arterial disease.
    Salmasi AM; Salmasi S; MacDonald G; Nicolaides AN
    Int J Cardiol; 1991 Apr; 31(1):71-80. PubMed ID: 2071252
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The calcium channel blocker nisoldipine delays progression of chronic renal failure in humans (preliminary communication).
    Eliahou HE; Cohen D; Ben-David A; Herzog D; Serban I; Gavendo S; Kapuler S; Kogan N; Hellberg B
    Cardiovasc Drugs Ther; 1988 Jan; 1(5):523-8. PubMed ID: 3154680
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Comparison of the anti-ischemia effect of nisoldipine and verapamil. Double-blind randomized cross-over and placebo-controlled acute and long-term study].
    Brügmann U; Blasini R; Rudolph W
    Herz; 1984 Aug; 9(4):244-52. PubMed ID: 6434387
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sex differences in coronary atherosclerosis progression and major adverse cardiac events in patients with suspected coronary artery disease.
    Gu H; Gao Y; Wang H; Hou Z; Han L; Wang X; Lu B
    J Cardiovasc Comput Tomogr; 2017; 11(5):367-372. PubMed ID: 28754436
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adverse cardiovascular events arising from atherosclerotic lesions with and without angiographic disease progression.
    Sanidas EA; Mintz GS; Maehara A; Cristea E; Wennerblom B; Iñiguez A; Fajadet J; Fahy M; Dressler O; Weisz G; Templin B; Zhang Z; Lansky AJ; de Bruyne B; Serruys P; Stone GW
    JACC Cardiovasc Imaging; 2012 Mar; 5(3 Suppl):S95-S105. PubMed ID: 22421236
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design features of the Avasimibe and Progression of coronary Lesions assessed by intravascular UltraSound (A-PLUS) clinical trial.
    Tardif JC; Grégoire J; Lespérance J; Lambert J; L'Allier PL; Rodés J; Anderson T; Blue JW; Imus J; Heinonen T
    Am Heart J; 2002 Oct; 144(4):589-96. PubMed ID: 12360153
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coronary bypass surgery versus stenting in multivessel disease involving the proximal left anterior descending coronary artery.
    Cavalcante R; Sotomi Y; Zeng Y; Lee CW; Ahn JM; Collet C; Tenekecioglu E; Suwannasom P; Onuma Y; Park SJ; Serruys PW
    Heart; 2017 Mar; 103(6):428-433. PubMed ID: 27651390
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Progression of coronary artery disease predicts clinical coronary events. Long-term follow-up from the Cholesterol Lowering Atherosclerosis Study.
    Azen SP; Mack WJ; Cashin-Hemphill L; LaBree L; Shircore AM; Selzer RH; Blankenhorn DH; Hodis HN
    Circulation; 1996 Jan; 93(1):34-41. PubMed ID: 8616937
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nisoldipine improves ventricular function in rats with ischemic heart failure.
    Capasso JM
    J Mol Cell Cardiol; 1995 Sep; 27(9):1841-9. PubMed ID: 8523445
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Results and clinical implications of the CAPARES trial.
    Thaulow E; Jorgensen B
    Can J Cardiol; 2000 Jul; 16 Suppl D():8D-11D. PubMed ID: 10932030
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Monitored Atherosclerosis Regression Study (MARS). Design, methods and baseline results.
    Cashin-Hemphill L; Kramsch DM; Azen SP; DeMets D; DeBoer LW; Hwang I; Vailas L; Hirsch LJ; Mack WJ; DeBoer L
    Online J Curr Clin Trials; 1992 Oct; Doc No 26():[9897 words; 83 paragraphs]. PubMed ID: 1343613
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Calcium-channel blockers for hypertension--uncertainty continues.
    Cutler JA
    N Engl J Med; 1998 Mar; 338(10):679-81. PubMed ID: 9486999
    [No Abstract]   [Full Text] [Related]  

  • 35. Concept of an antiatherosclerotic efficacy of calcium entry blockers. INTACT Investigators.
    Jost S; Rafflenbeul W; Deckers J; Wiese B; Hecker H; Nikutta P; Lippolt P; Lichtlen P
    Eur J Epidemiol; 1992 May; 8 Suppl 1():107-19. PubMed ID: 1505647
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nisoldipine coat-core. A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in the management of ischaemic heart disease.
    Langtry HD; Spencer CM
    Drugs; 1997 May; 53(5):867-84. PubMed ID: 9129871
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of progression or regression of coronary artery atherosclerosis with long-term prognosis.
    Ndrepepa G; Iijima R; Kufner S; Braun S; Cassese S; Byrne RA; Sorges J; Schulz-Schüpke S; Hoppmann P; Fussaro M; Laugwitz KL; Schunkert H; Kastrati A
    Am Heart J; 2016 Jul; 177():9-16. PubMed ID: 27297844
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term effect of perindopril on coronary atherosclerosis progression (from the perindopril's prospective effect on coronary atherosclerosis by angiography and intravascular ultrasound evaluation [PERSPECTIVE] study).
    Rodriguez-Granillo GA; Vos J; Bruining N; Garcia-Garcia HM; de Winter S; Ligthart JM; Deckers JW; Bertrand M; Simoons ML; Ferrari R; Fox KM; Remme W; De Feyter PJ;
    Am J Cardiol; 2007 Jul; 100(2):159-63. PubMed ID: 17631061
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Progression of coronary artery atherosclerosis after acute myocardial infarction: an angiographic study.
    Hawranek M; Gasior M; Gierlotka M; Wilczek K; Lekston A; Szygula-Jurkiewicz B; Spatuszko A; Polonski L
    J Invasive Cardiol; 2010 May; 22(5):209-15. PubMed ID: 20440036
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of long term cholesterol lowering on coronary atherosclerosis in patient risk factor subgroups: the Simvastatin/enalapril Coronary Atherosclerosis Trial (SCAT).
    Burton JR; Teo KK; Buller CE; Plante S; Catellier D; Tymchak W; Taylor D; Dzavik V; Montague TJ;
    Can J Cardiol; 2003 Apr; 19(5):487-91. PubMed ID: 12717482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.